163 related articles for article (PubMed ID: 14571469)
1. Mononeuropathy multiplex in association with livedoid vasculitis.
Toth C; Trotter M; Clark A; Zochodne D
Muscle Nerve; 2003 Nov; 28(5):634-9. PubMed ID: 14571469
[TBL] [Abstract][Full Text] [Related]
2. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?
Acland KM; Darvay A; Wakelin SH; Russell-Jones R
Br J Dermatol; 1999 Jan; 140(1):131-5. PubMed ID: 10215783
[TBL] [Abstract][Full Text] [Related]
3. Vascular ulcers in scleroderma.
Thomas JR; Winkelmann RK
Arch Dermatol; 1983 Oct; 119(10):803-7. PubMed ID: 6137196
[TBL] [Abstract][Full Text] [Related]
4. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous eosinophilic vasculitis associated with rheumatoid arthritis.
Yomoda M; Inoue M; Nakama T; Mori O; Chen KR; Hashimoto T
Br J Dermatol; 1999 Apr; 140(4):754-5. PubMed ID: 10233338
[No Abstract] [Full Text] [Related]
6. The vasculitis of atrophie blanche (livedoid vasculitis) and abdominal aortic pathology.
Schroeter AL; Harris RB
Cutis; 1984 Sep; 34(3):298-302. PubMed ID: 6488886
[TBL] [Abstract][Full Text] [Related]
7. Refractory livedoid vasculitis responding to PUVA: a report of four cases.
Tuchinda C; Leenutaphong V; Sudtim S; Lim HW
Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):154-6. PubMed ID: 15888134
[TBL] [Abstract][Full Text] [Related]
8. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.
Hairston BR; Davis MD; Gibson LE; Drage LA
Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383
[No Abstract] [Full Text] [Related]
9. Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome.
Liao YH; Su YW; Tsay W; Chiu HC
Arch Dermatol; 2005 Aug; 141(8):1051-3. PubMed ID: 16103348
[No Abstract] [Full Text] [Related]
10. [Cutaneous vasculitis].
Doutre MS; Beylot C; Beylot J
Ann Pathol; 1992; 12(4-5):263-7. PubMed ID: 1466682
[No Abstract] [Full Text] [Related]
11. Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.
Gotlib J; Kohler S; Reicherter P; Oro AE; Zehnder JL
Arch Dermatol; 2003 Aug; 139(8):1081-3. PubMed ID: 12925402
[No Abstract] [Full Text] [Related]
12. Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: a case report.
Jeruc J; Popovic M; Vizjak A; Jurcić V; Lestan B; Ferluga D
Folia Neuropathol; 2006; 44(2):140-3. PubMed ID: 16823697
[TBL] [Abstract][Full Text] [Related]
13. [Idiopathic atrophie blanche or livedoid vasculitis].
Yebra Bango M; Simón Merchán A; Sanz Ortega E; Vargas Núñez JA
Rev Clin Esp; 1987 Feb; 180(3):175-6. PubMed ID: 3575833
[No Abstract] [Full Text] [Related]
14. Localized neurological necrotizing vasculitides. Three cases with isolated mononeuritis multiplex.
Abgrall S; Mouthon L; Cohen P; Authier FJ; Nizou R; Ropert A; Ghérardi R; Guillevin L
J Rheumatol; 2001 Mar; 28(3):631-3. PubMed ID: 11296972
[TBL] [Abstract][Full Text] [Related]
15. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
[TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences.
Meiss F; Marsch WC; Fischer M
Eur J Dermatol; 2006; 16(2):159-62. PubMed ID: 16581568
[TBL] [Abstract][Full Text] [Related]
17. Atrophie blanche--a special form of vasculopathy.
Kwok CY; Cheong WK
Singapore Med J; 1997 Mar; 38(3):123-4. PubMed ID: 9269380
[TBL] [Abstract][Full Text] [Related]
18. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
19. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
